JPRN-jRCT1030220247已完成未知
A study of the safety and sustainability of pain therapy with human adipose-derived mesenchymal stem cell conditioned medium
Suzuki Hidehiko0 个研究点目标入组 12 人开始时间: 2022年8月5日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
入选标准
- •1. Patients with chronic pain
- •2. Patients who did not have a satisfactory pain relief effect with standard treatment
- •3. Patients who do not wish to be treated with the drugs used in standard of care
- •4. Patients over 18 years old
- •5. Patients with normal consent ability
- •6. Patients who can obtain their free will consent in writing
- •7. Patients whose doctor recognizes the need for treatment
排除标准
- •1. Patients with a history or suspicion of malignant tumor or dementia
- •2. Drug and stimulant users
- •3. Patients with no pain other than psychogenic pain
- •4. Patients who do not understand and agree with this treatment
- •5. Pregnant
- •6. Patients that the doctor in charge deems inappropriate
研究者
相似试验
招募中
Unknown
A study of the safety and sustainability of pain therapy with conditioned mediumChronic PainD059350JPRN-jRCT1030220346eda Yasuo
招募中
Unknown
A study of the safety and sustainability of pain therapy with conditioned mediumChronic PainD059350JPRN-jRCT1050230167Suzuki Hidehiko50
招募中
Unknown
A study of the safety and sustainability of pain therapy with conditioned mediumJPRN-jRCT1050230092Taketomi Masanori
招募中
1 期
The effect of empagliflozin on proteinuriaIRCT20220405054414N1Iran University of Medical Sciences15
招募中
不适用
A study to assess the safety, tolerability, and pharmacokinetics of FM101 after single and multiple ascending dose administration to healthy subjects.ASH (non-alcoholic steatohepatitis)NL-OMON27747Future Medicine Ltd.50